Beranda › Limfoma Non-Hodgkin › Distrik Columbia › Washington
Uji klinis Limfoma Non-Hodgkin di Washington, DC
18 studi untuk Limfoma Non-Hodgkin mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Menerima pesertaFase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mi jauhnya
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Menerima pesertaFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Menerima pesertaFase 3
- GC2202 Study Site 111, Bethesda · 7 mi jauhnya
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Menerima pesertaFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Tissue Collection for Studies of Lymph Cancer
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Menerima pesertaStudi observasional
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Menerima pesertaFase 1/2
- Children's National Medical Center, Washington D.C.
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Menerima pesertaFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Menerima pesertaFase 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi jauhnya
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Menerima pesertaFase 3
- MedStar Georgetown University Hospital, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi jauhnya
- Nih/Nhlbi, Bethesda · 7 mi jauhnya
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Menerima pesertaFase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauhnya
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauhnya
Uji klinis Limfoma Non-Hodgkin di kota lain
- New York City, NY31 studi
- Houston, TX31 studi
- Boston, MA26 studi
- Nashville, TN21 studi
- Philadelphia, PA20 studi
- Baldwin Park, CA19 studi
- Atlanta, GA18 studi
- Milwaukee, WI18 studi
- Chicago, IL18 studi
- Columbus, OH18 studi
- Dallas, TX17 studi
- Seattle, WA16 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Metastatik43 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Kanker Kandung Kemih26 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.